John Puetz

1.0k total citations
25 papers, 801 citations indexed

About

John Puetz is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, John Puetz has authored 25 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 7 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in John Puetz's work include Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). John Puetz is often cited by papers focused on Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). John Puetz collaborates with scholars based in United States, Switzerland and Czechia. John Puetz's co-authors include Kirk R. Thomas, Florian Μ. Wurm, Mario R. Capecchi, Seth D. Crosby, Jeffrey Milbrandt, Timothy J. Fahrner, K S Simburger, Christine L. Kempton, Paul E. Monahan and J. Michael Soucie and has published in prestigious journals such as Nature, Molecular and Cellular Biology and The Journal of Pediatrics.

In The Last Decade

John Puetz

22 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Puetz United States 12 461 178 145 101 59 25 801
Bjørnar Olaisen Norway 16 352 0.8× 76 0.4× 310 2.1× 29 0.3× 46 0.8× 32 769
Silvia Pulido United States 8 254 0.6× 160 0.9× 92 0.6× 29 0.3× 54 0.9× 12 547
Anamika Singh India 17 442 1.0× 45 0.3× 215 1.5× 46 0.5× 21 0.4× 36 937
Akinori Kawamura Japan 16 588 1.3× 120 0.7× 116 0.8× 19 0.2× 28 0.5× 41 810
Oliver M. Dovey United Kingdom 12 962 2.1× 133 0.7× 118 0.8× 28 0.3× 93 1.6× 17 1.1k
Cristian Bellodi Sweden 18 1.2k 2.5× 109 0.6× 93 0.6× 16 0.2× 27 0.5× 27 1.4k
Michael Wallisch United States 13 988 2.1× 216 1.2× 192 1.3× 33 0.3× 226 3.8× 33 1.4k
Christian Rohde Germany 18 1.1k 2.4× 132 0.7× 211 1.5× 18 0.2× 36 0.6× 38 1.3k
Amanda Formosa Italy 12 749 1.6× 56 0.3× 134 0.9× 48 0.5× 30 0.5× 19 1.2k
Ronan Quéré France 15 423 0.9× 149 0.8× 52 0.4× 14 0.1× 55 0.9× 33 669

Countries citing papers authored by John Puetz

Since Specialization
Citations

This map shows the geographic impact of John Puetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Puetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Puetz more than expected).

Fields of papers citing papers by John Puetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Puetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Puetz. The network helps show where John Puetz may publish in the future.

Co-authorship network of co-authors of John Puetz

This figure shows the co-authorship network connecting the top 25 collaborators of John Puetz. A scholar is included among the top collaborators of John Puetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Puetz. John Puetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puetz, John. (2025). Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxes. Journal of Thrombosis and Haemostasis. 23(6). 1767–1770.
2.
Puetz, John. (2024). Hemophilia Gene Therapy: Another Blessing or Another Curse?. PubMed. 121(3). 231–234.
3.
Puetz, John. (2023). Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus. Frontiers in Medicine. 10. 1256919–1256919. 1 indexed citations
4.
Puetz, John, et al.. (2023). Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdataset. Pediatric Blood & Cancer. 70(11). e30644–e30644. 3 indexed citations
5.
Puetz, John. (2021). Are there additive effects between emicizumab and factor VIII?. Journal of Thrombosis and Haemostasis. 19(2). 596–596.
6.
Puetz, John & Dunlei Cheng. (2021). Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset. Haemophilia. 27(6). 1045–1050. 10 indexed citations
7.
Puetz, John. (2018). Nano‐evidence for joint microbleeds in hemophilia patients. Journal of Thrombosis and Haemostasis. 16(10). 1914–1917. 11 indexed citations
8.
Moser, Karen & John Puetz. (2015). Challenging hemostasis scenarios in pediatric patients – two case studies. International Journal of Laboratory Hematology. 37(S1). 72–77. 5 indexed citations
9.
Puetz, John, J. Michael Soucie, Christine L. Kempton, & Paul E. Monahan. (2013). Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database. Haemophilia. 20(1). 25–31. 50 indexed citations
10.
Kurth, Margaret, John Puetz, Peter A. Kouides, et al.. (2011). The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience. Journal of Thrombosis and Haemostasis. 9(11). 2229–2234. 39 indexed citations
11.
Puetz, John, Char Witmer, Yuan‐Shung Huang, & Leslie Raffini. (2011). Widespread Use of Fresh Frozen Plasma in US Children’s Hospitals Despite Limited Evidence Demonstrating a Beneficial Effect. The Journal of Pediatrics. 160(2). 210–215.e1. 44 indexed citations
12.
Puetz, John. (2010). Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients. Drug Design Development and Therapy. 4. 127–127. 4 indexed citations
13.
Puetz, John, et al.. (2009). Fresh Frozen Plasma and Recombinant Factor VIIa Use in Neonates. Journal of Pediatric Hematology/Oncology. 31(12). 901–906. 16 indexed citations
14.
Puetz, John, et al.. (2009). Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatric Blood & Cancer. 53(6). 1074–1078. 13 indexed citations
15.
Puetz, John & Timothy J. Fete. (2005). Platelet Function Disorder in Gardner-Diamond Syndrome. Journal of Pediatric Hematology/Oncology. 27(6). 323–325. 14 indexed citations
16.
17.
Puetz, John, et al.. (2004). Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies. Thrombosis and Haemostasis. 91(4). 819–821. 4 indexed citations
18.
Puetz, John, et al.. (2001). High‐titre factor VIII inhibitor in two children with mild haemophilia A. Haemophilia. 7(2). 215–219. 5 indexed citations
19.
Puetz, John, et al.. (2000). Maintenance of functional equivalence during paralogous Hox gene evolution. Nature. 403(6770). 661–665. 204 indexed citations
20.
Crosby, Seth D., John Puetz, K S Simburger, Timothy J. Fahrner, & Jeffrey Milbrandt. (1991). The Early Response Gene NGFI-C Encodes a Zinc Finger Transcriptional Activator and Is a Member of the GCGGGGGCG (GSG) Element-Binding Protein Family. Molecular and Cellular Biology. 11(8). 3835–3841. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bjørnar Olaisen Breakdown of academic impact, for papers by Silvia Pulido Breakdown of academic impact, for papers by Anamika Singh Breakdown of academic impact, for papers by Akinori Kawamura Breakdown of academic impact, for papers by Oliver M. Dovey Breakdown of academic impact, for papers by Cristian Bellodi Breakdown of academic impact, for papers by Michael Wallisch Breakdown of academic impact, for papers by Christian Rohde Breakdown of academic impact, for papers by Amanda Formosa Breakdown of academic impact, for papers by Ronan Quéré
Rankless by CCL
2026